Belite Bio, Inc. (BLTE)
149.61
-4.07
(-2.65%)
USD |
NASDAQ |
Jan 15, 16:00
149.33
-0.28
(-0.19%)
After-Hours: 20:00
Belite Bio SG&A Expense (TTM): 29.58M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ocugen, Inc. | 27.76M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| Ligand Pharmaceuticals, Inc. | 93.03M |
| IDEAYA Biosciences, Inc. | 55.43M |
| Terns Pharmaceuticals, Inc. | 31.48M |